PMID- 1331778 OWN - NLM STAT- MEDLINE DCOM- 19921221 LR - 20081121 IS - 0888-8809 (Print) IS - 0888-8809 (Linking) VI - 6 IP - 9 DP - 1992 Sep TI - Heterodimerization among thyroid hormone receptor, retinoic acid receptor, retinoid X receptor, chicken ovalbumin upstream promoter transcription factor, and an endogenous liver protein. PG - 1468-78 AB - Thyroid hormone receptor (TR) binds to DNA as a monomer, homodimer, and heterodimer with nuclear proteins. We have confirmed that the TR can heterodimerize with retinoid X receptors (RXRs)-alpha and -beta, and have found that another member of the nuclear receptor superfamily, chicken ovalbumin upstream promoter transcription factor (COUP-TF), also formed heterodimers with the TR in the context of binding to a palindromic thyroid hormone-responsive element (TREp). The interaction between COUP-TF and the TR was confirmed using specific antibodies which supershifted the COUP-TF/TR DNA complexes. The complex between the TR and the major TR heterodimerization partner in liver was unaffected by antibodies to COUP-TF and RXR beta, but was supershifted by an anti-RXR alpha antibody, indicating that the liver protein is highly related to RXR alpha. Indeed, the TR/RXR and TR/liver protein heterodimers contact the same guanidine residues in TREp. The retinoic acid receptor (RAR) also heterodimerized with COUP-TF as well as with RXR alpha, RXR beta, and the TR heterodimerization partner in liver. In contrast to its ability to heterodimerize with the TR and RAR, we did not detect heterodimers between COUP-TF and either RXR alpha, RXR beta, or the liver nuclear protein in the context of binding to the TREp. These results show that the major TR heterodimerization partner in liver is highly related to RXR alpha, but that other nuclear receptors such as COUP-TF can heterodimerize with the TR and RAR, suggesting that selective protein-protein interactions may be involved in the tissue and target gene specificities of hormone action. FAU - Berrodin, T J AU - Berrodin TJ AD - Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104. FAU - Marks, M S AU - Marks MS FAU - Ozato, K AU - Ozato K FAU - Linney, E AU - Linney E FAU - Lazar, M A AU - Lazar MA LA - eng GR - 1RO1-DK-43806-01/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Mol Endocrinol JT - Molecular endocrinology (Baltimore, Md.) JID - 8801431 RN - 0 (COUP Transcription Factor I) RN - 0 (Carrier Proteins) RN - 0 (DNA-Binding Proteins) RN - 0 (Nuclear Proteins) RN - 0 (Receptors, Cell Surface) RN - 0 (Receptors, Retinoic Acid) RN - 0 (Receptors, Thyroid Hormone) RN - 0 (Recombinant Fusion Proteins) RN - 0 (Retinoid X Receptors) RN - 0 (Transcription Factors) RN - 9007-49-2 (DNA) SB - IM MH - Animals MH - Binding Sites MH - COUP Transcription Factor I MH - Carrier Proteins/*metabolism MH - DNA/metabolism MH - DNA-Binding Proteins/*metabolism MH - Liver/*chemistry MH - Nuclear Proteins/*metabolism MH - Protein Binding MH - Protein Conformation MH - *Protein Multimerization MH - Receptors, Cell Surface/*metabolism MH - Receptors, Retinoic Acid MH - Receptors, Thyroid Hormone/*metabolism MH - Recombinant Fusion Proteins/metabolism MH - Regulatory Sequences, Nucleic Acid MH - Retinoid X Receptors MH - Transcription Factors/*metabolism EDAT- 1992/09/01 00:00 MHDA- 1992/09/01 00:01 CRDT- 1992/09/01 00:00 PHST- 1992/09/01 00:00 [pubmed] PHST- 1992/09/01 00:01 [medline] PHST- 1992/09/01 00:00 [entrez] AID - 10.1210/mend.6.9.1331778 [doi] PST - ppublish SO - Mol Endocrinol. 1992 Sep;6(9):1468-78. doi: 10.1210/mend.6.9.1331778.